We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.42B
AUM Growth
+$53.3M
(+3.9%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
26.02%
Holding
276
New
21
Increased
128
Reduced
73
Closed
13
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.96M |
| 2 |
Merck
MRK
|
+$6.29M |
| 3 |
UnitedHealth
UNH
|
+$5.85M |
| 4 |
Amazon
AMZN
|
+$5.11M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$11.9M |
| 2 |
Cardinal Health
CAH
|
+$9.07M |
| 3 |
AT&T
T
|
+$3.98M |
| 4 |
Medtronic
MDT
|
+$3.36M |
| 5 |
Estee Lauder
EL
|
+$2.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.84% |
| 2 | Healthcare | 14.41% |
| 3 | Technology | 13.82% |
| 4 | Industrials | 11.14% |
| 5 | Energy | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Edwards Lifesciences
EW
$49.4B
| $1.87M | 0.13% |
60,000
| – | – |
2016 Q3
1 quarter
|
|
102
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $1.87M | 0.13% |
+77,188
| New | +$1.84M |
2016 Q4
0 quarters
|
|
|
RTN
103
DELISTED
Raytheon Company
RTN
| $1.81M | 0.13% |
12,719
| – | – |
2013 Q2
14 quarters
|
|
104
Independent Bank
INDB
$3.66B
| $1.73M | 0.12% |
24,490
| – | – |
2013 Q2
14 quarters
|
|
105
iShares Russell 2000 Growth ETF
IWO
$13.5B
| $1.69M | 0.12% |
10,950
+59
| +0.5% | +$8.81K |
2015 Q3
5 quarters
|
|
106
Travelers Companies
TRV
$79.8B
| $1.62M | 0.11% |
13,266
+21
| +0.2% | +$2.4K |
2013 Q2
14 quarters
|
|
107
iShares Russell Mid-Cap ETF
IWR
$56B
| $1.58M | 0.11% |
35,400
| – | – |
2013 Q2
14 quarters
|
|
108
iShares Core S&P Small-Cap ETF
IJR
$102B
| $1.5M | 0.11% |
21,826
+520
| +2% | +$33.5K |
2013 Q2
14 quarters
|
|
109
Emerson Electric
EMR
$87.9B
| $1.46M | 0.1% |
26,224
+1,790
| +7% | +$96.3K |
2013 Q2
14 quarters
|
|
110
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $1.46M | 0.1% |
44,205
+11,480
| +35% | +$364K |
2013 Q2
14 quarters
|
|
111
Boeing
BA
$147B
| $1.43M | 0.1% |
9,165
+1,705
| +23% | +$249K |
2013 Q2
14 quarters
|
|
112
iShares Core S&P 500 ETF
IVV
$885B
| $1.38M | 0.1% |
6,125
-86
| -1% | -$18.9K |
2014 Q3
9 quarters
|
|
113
McKesson
MCK
$116B
| $1.38M | 0.1% |
9,813
-144
| -1% | -$21.2K |
2013 Q2
14 quarters
|
|
114
American Express
AXP
$208B
| $1.36M | 0.1% |
18,383
+1,544
| +9% | +$107K |
2013 Q2
14 quarters
|
|
115
Church & Dwight Co
CHD
$24.9B
| $1.33M | 0.09% |
30,100
| – | – |
2016 Q2
2 quarters
|
|
116
Nike
NKE
$54.8B
| $1.23M | 0.09% |
24,135
-25
| -0.1% | -$1.28K |
2013 Q2
14 quarters
|
|
117
Dominion Energy
D
$55.3B
| $1.21M | 0.09% |
15,805
-666
| -4% | -$49.1K |
2013 Q2
14 quarters
|
|
118
iShares Select Dividend ETF
DVY
$23.1B
| $1.21M | 0.09% |
13,637
-366
| -3% | -$31.5K |
2013 Q2
14 quarters
|
|
119
State Street Health Care Select Sector SPDR ETF
XLV
$46.1B
| $1.17M | 0.08% |
+16,925
| New | +$1.18M |
2016 Q4
0 quarters
|
|
120
Vanguard High Dividend Yield ETF
VYM
$81.3B
| $1.16M | 0.08% |
15,338
-1,060
| -6% | -$77.8K |
2013 Q2
14 quarters
|
|
|
CCMP
121
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.15M | 0.08% |
18,124
| – | – |
2013 Q2
14 quarters
|
|
122
Air Products & Chemicals
APD
$65.6B
| $1.12M | 0.08% |
7,800
-634
| -8% | -$88.7K |
2013 Q2
14 quarters
|
|
123
Skyworks Solutions
SWKS
$18.3B
| $1.12M | 0.08% |
15,000
| – | – |
2016 Q2
2 quarters
|
|
124
Chubb
CB
$138B
| $1.09M | 0.08% |
8,257
+896
| +12% | +$114K |
2016 Q1
3 quarters
|
|
125
Idexx Laboratories
IDXX
$42.7B
| $1.02M | 0.07% |
8,736
| – | – |
2016 Q2
2 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q4 2016 Portfolio in Review
As of Q4 2016, Cambridge Trust held 276 positions worth $1.42B, up 3.9% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cambridge Trust's Q4 2016 filing shows 21 new, 128 increased, 73 reduced and 13 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M. The largest sale was Novartis, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Cambridge Trust's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M.
- Cambridge Trust added most to Celgene Corp in Q4 2016, an estimated $6.96M increase.
- Cambridge Trust's biggest Q4 2016 reduction was Novartis, cutting an estimated $11.9M.
- Cambridge Trust fully exited Cardinal Health in Q4 2016, selling an estimated $9.07M.
- Cambridge Trust's ten largest holdings make up 26% of its $1.42B portfolio in Q4 2016.
- Cambridge Trust opened 21 new positions and closed 13 in Q4 2016.
- Cambridge Trust's portfolio value rose 3.9% quarter-over-quarter to $1.42B.
Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.